Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation.
about
New surfactant with SP-B and C analogs gives survival benefit after inactivation in preterm lambsEffects of graphene oxide nanosheets on the ultrastructure and biophysical properties of the pulmonary surfactant filmPulmonary surfactant pathophysiology: current models and open questionsBiophysical influence of airborne carbon nanomaterials on natural pulmonary surfactantComparative study of clinical pulmonary surfactants using atomic force microscopyPhysicochemical properties of nanoparticles regulate translocation across pulmonary surfactant monolayer and formation of lipoprotein coronaRab38 targets to lamellar bodies and normalizes their sizes in lung alveolar type II epithelial cells.Biosurfactants for microbubble preparation and applicationSurfactant protein SP-B strongly modifies surface collapse of phospholipid vesicles: insights from a quartz crystal microbalance with dissipation.Rediscovering the Schulze-Hardy rule in competitive adsorption to an air-water interfaceLamellar bodies form solid three-dimensional films at the respiratory air-liquid interface.Effects of the lung surfactant protein B construct Mini-B on lipid bilayer order and topographyRole of the N-terminal seven residues of surfactant protein B (SP-B)Interaction of the C-terminal peptide of pulmonary surfactant protein B (SP-B) with a bicellar lipid mixture containing anionic lipid.Environmental tobacco smoke effects on lung surfactant film organization.Overcoming rapid inactivation of lung surfactant: analogies between competitive adsorption and colloid stability.Comparative proteomic analysis of lung lamellar bodies and lysosome-related organellesThe effect of matrix metalloproteinase-3 deficiency on pulmonary surfactant in a mouse model of acute lung injury.Retinoic acid is a key regulatory switch determining the difference between lung and thyroid fates in Xenopus laevis.Lipid polymorphism induced by surfactant peptide SP-B(1-25)Comparative genomics of pneumocystis species suggests the absence of genes for myo-inositol synthesis and reliance on inositol transport and metabolism.Meconium impairs pulmonary surfactant by a combined action of cholesterol and bile acids.Comparative evaluation of heterologous production systems for recombinant pulmonary surfactant protein D.In vivo effect of pneumonia on surfactant disaturated-phosphatidylcholine kinetics in newborn infantsInfluence of molecular coherence on surface viscosity.Surface film formation in vitro by infant and therapeutic surfactants: role of surfactant protein B.Anionic pulmonary surfactant lipid regulation of innate immunityLipid-protein interactions alter line tensions and domain size distributions in lung surfactant monolayersLiver cold preservation induce lung surfactant changes and acute lung injury in rat liver transplantation.Lung Beractant Increases Free Cytosolic Levels of Ca2+ in Human Lung FibroblastsVisualizing the analogy between competitive adsorption and colloid stability to restore lung surfactant functionDifferential effects of cholesterol and budesonide on biophysical properties of clinical surfactant.Surfactant protein B inhibits secretory phospholipase A2 hydrolysis of surfactant phospholipids.Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometerEffect of clay nanoparticles on model lung surfactant: a potential marker of hazard from nanoaerosol inhalationProtective effects of thoracic epidural anesthesia on hypoxia-induced acute lung injury in rabbits.On the low surface tension of lung surfactant.Atomic force microscopy studies of functional and dysfunctional pulmonary surfactant films, II: albumin-inhibited pulmonary surfactant films and the effect of SP-ACigarette Smoke Induces Human Epidermal Receptor 2-Dependent Changes in Epithelial Permeability.Carcinoembryonic cell adhesion molecule 6 in human lung: regulated expression of a multifunctional type II cell protein.
P2860
Q27313764-F6B8B57D-2B65-4F42-9D1A-4341DEF84E17Q27334324-CC06CE0D-66F9-4CDE-AB04-FA6777732D29Q28285439-7015F91B-BB56-4306-9C6C-734B3F4639ADQ28393750-50B34853-E634-4C6D-BA51-78847F7A3C1CQ28833705-1E080DFA-44C9-450D-94F3-59DEA6EB52DCQ29248541-1AA2201C-7B4D-4F34-B9F3-D919D3DFF37DQ30462793-1F1278DA-C1C7-40D2-A917-37A0239935B7Q30476936-79C00BB3-493E-4ABE-863D-9A5B29B205BBQ30480082-7DBA9CB8-81FB-4F06-A0A1-E790EEBC19FFQ30489870-00C88C34-9B2E-4D08-AC41-6E7D3C699312Q30496453-46F13380-12AC-4E08-BF3B-D22FB7A2CBA7Q30558222-6BC4BA48-E57A-48A4-9F1C-955A7F716A9BQ30666184-31CFB867-B5C5-435E-A2F3-41899D209E2EQ31132585-23DF9590-EE25-4CB0-B97F-508DE80B6693Q33396842-A460B8D5-9355-4270-BF61-8BDBA3D02BDBQ33712598-63A74599-9907-4FA6-BBB1-B392B20C3A1CQ33813328-E58005F7-8EA1-49EF-9769-42B38699E99EQ33924226-3C151B59-2BC8-455F-A87E-357286F63EB3Q34106746-878FE684-FC96-4C37-830B-DC6CBC7BC9ABQ34134743-E2FC75C6-12DF-4C38-B01B-E9344E30B8D3Q34461881-0D4E276C-09AB-4958-A6C7-61B7EBCDA597Q34536194-D0698982-7F48-4B69-8A0B-64E4C8C69BC5Q34652077-C3EA6028-4629-4F19-91A0-9F297CCCD7C1Q34796387-68ACBBDE-1144-48F5-99B3-2705EB4F67E8Q35100681-30584B43-73C8-4BEF-BFD4-B86E0BF4EC0FQ35346235-6BCC7891-1686-4737-BA95-71158DFA9E11Q35648698-6E8377E9-0FEE-44B3-92C4-F24C658022ACQ35649508-DEF7E657-730B-431A-9852-5CE045648EE3Q35681505-0CD337CE-1EC6-417A-BEF9-1FD86704B5A2Q35730407-4C6E3C2B-1C77-4D11-BB4B-5BA20B674097Q35769953-71E68291-A05A-4F3B-A6A1-A55FF0CA2E9DQ35917662-680714D4-EE70-44D0-BECC-CA9A02084E09Q35950137-6B9FAB9F-75FF-44D8-82DC-83C788FC600BQ36318031-AD39BFA1-5810-4C64-A98A-2C410777D673Q36615037-1F09B9B3-3193-48D9-A218-0BCC92F10098Q36824802-1CFDE81F-1E8B-4D49-8595-7F58CC55160DQ36849340-840DB671-7DBE-4DCB-A28F-918E264EDE16Q36856485-BAE2278C-0219-425F-8C27-D97053891842Q37088300-9233E8A6-BC82-417B-9B4E-B65469612E73Q37218048-B6BA8489-63C7-459B-B704-826212D1AD31
P2860
Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation.
@en
Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation.
@nl
type
label
Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation.
@en
Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation.
@nl
prefLabel
Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation.
@en
Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation.
@nl
P2093
P1476
Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation
@en
P2093
A Wilhelm Neumann
Fred Possmayer
Nils O Petersen
P304
P356
10.1016/J.BBAMEM.2008.03.021
P407
P577
2008-04-08T00:00:00Z